{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:02:15Z","timestamp":1782990135784,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013394","name":"Instituto Nacional de Medicina Gen\u00f3mica","doi-asserted-by":"publisher","award":["403"],"award-info":[{"award-number":["403"]}],"id":[{"id":"10.13039\/501100013394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"CONACYT","doi-asserted-by":"publisher","award":["CB-182450"],"award-info":[{"award-number":["CB-182450"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"CONACYT","doi-asserted-by":"publisher","award":["CF-2019 - 85552"],"award-info":[{"award-number":["CF-2019 - 85552"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.bbamcr.2022.119222","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T22:04:31Z","timestamp":1643407471000},"page":"119222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparative subcellular localization of NRF2 and KEAP1 during the hepatocellular carcinoma development in vivo"],"prefix":"10.1016","volume":"1869","author":[{"given":"Dafne","family":"Guerrero-Escalera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brisa Rodope","family":"Alarc\u00f3n-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Arellanes-Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Cruz-Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"del Pozo-Yauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Chagoya de S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osbaldo","family":"Resendis-Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul","family":"Villa-Trevi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Esperanza","family":"Torres-Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio Isael","family":"P\u00e9rez-Carre\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bbamcr.2022.119222_bb0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.bbamcr.2022.119222_bb0010","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment","volume":"6","author":"Farazi","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbamcr.2022.119222_bb0015","doi-asserted-by":"crossref","first-page":"8341286","DOI":"10.1155\/2017\/8341286","article-title":"Oxidative stress in liver diseases: pathogenesis, prevention, and therapeutics","volume":"2017","author":"Jadeja","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbamcr.2022.119222_bb0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.freeradbiomed.2016.11.027","article-title":"Ptgr1 expression is regulated by NRF2 in rat hepatocarcinogenesis and promotes cell proliferation and resistance to oxidative stress","volume":"102","author":"Sanchez-Rodriguez","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.bbamcr.2022.119222_bb0025","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1128\/MCB.22.9.2883-2892.2002","article-title":"Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter","volume":"22","author":"Kwak","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.bbamcr.2022.119222_bb0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.taap.2009.08.028","article-title":"Targeting NRF2 signaling for cancer chemoprevention","volume":"244","author":"Kwak","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"7354","key":"10.1016\/j.bbamcr.2022.119222_bb0035","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature10189","article-title":"Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis","volume":"475","author":"DeNicola","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbamcr.2022.119222_bb0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12032-017-0914-5","article-title":"Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression","volume":"34","author":"Ma-On","year":"2017","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.bbamcr.2022.119222_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","article-title":"NRF2 and the hallmarks of cancer","volume":"34","author":"Rojo de la Vega","year":"2018","journal-title":"Cancer Cell"},{"issue":"18","key":"10.1016\/j.bbamcr.2022.119222_bb0050","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1158\/0008-5472.CAN-16-3538","article-title":"Nrf2 mutagenic activation drives hepatocarcinogenesis","volume":"77","author":"Ngo","year":"2017","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbamcr.2022.119222_bb0055","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.critrevonc.2013.09.001","article-title":"Nrf2 is a potential therapeutic target in radioresistance in human cancer","volume":"88","author":"Zhou","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbamcr.2022.119222_bb0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.phrs.2018.06.013","article-title":"Canonical and non-canonical mechanisms of Nrf2 activation","volume":"134","author":"Silva-Islas","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.bbamcr.2022.119222_bb0065","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1128\/MCB.01704-07","article-title":"Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity","volume":"28","author":"Yamamoto","year":"2008","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.bbamcr.2022.119222_bb0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"20","key":"10.1016\/j.bbamcr.2022.119222_bb0075","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1093\/nar\/gks827","article-title":"Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks","volume":"40","author":"Hirotsu","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.bbamcr.2022.119222_bb0080","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.20538","article-title":"Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis","volume":"41","author":"Schiffer","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.bbamcr.2022.119222_bb0085","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/mc.23298","article-title":"Enrichment of progenitor cells by 2-acetylaminofluorene accelerates liver carcinogenesis induced by diethylnitrosamine in vivo","volume":"60","author":"Castro-Gil","year":"2021","journal-title":"Mol. Carcinog."},{"issue":"9","key":"10.1016\/j.bbamcr.2022.119222_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204583","article-title":"A new set of reference housekeeping genes for the normalization RT-qPCR data from the intestine of piglets during weaning","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bbamcr.2022.119222_bb0095","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"Pt 18","key":"10.1016\/j.bbamcr.2022.119222_bb0100","first-page":"4288","article-title":"Flightless, secreted through a late endosome\/lysosome pathway, binds LPS and dampens cytokine secretion","volume":"125","author":"Lei","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbamcr.2022.119222_bb0105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cotox.2016.10.007","article-title":"Dissecting the Keap1\/Nrf2 pathway through proteomics","volume":"1","author":"Tamir","year":"2016","journal-title":"Curr.Opin.Toxicol."},{"key":"10.1016\/j.bbamcr.2022.119222_bb0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.abb.2014.09.005","article-title":"Heme oxygenase-1 and anti-inflammatory M2 macrophages","volume":"564","author":"Naito","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbamcr.2022.119222_bb0115","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1186\/s12885-015-1541-1","article-title":"Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma","volume":"15","author":"Zhang","year":"2015","journal-title":"BMC Cancer"},{"issue":"18","key":"10.1016\/j.bbamcr.2022.119222_bb0120","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1128\/MCB.00630-07","article-title":"Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2","volume":"27","author":"Sun","year":"2007","journal-title":"Mol. Cell. Biol."},{"issue":"7","key":"10.1016\/j.bbamcr.2022.119222_bb0125","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.0308347100","article-title":"Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes","volume":"101","author":"Kang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bbamcr.2022.119222_bb0130","first-page":"2541","article-title":"Activation of the KEAP1NRF2ARE signaling pathway reduces oxidative stress in Hep2 cells","volume":"18","author":"Li","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.bbamcr.2022.119222_bb0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4174\/astr.2020.98.4.159","article-title":"Overexpression of Nrf2 promotes colon cancer progression via ERK and AKT signaling pathways","volume":"98","author":"Lee","year":"2020","journal-title":"Ann. Surg. Treat.Res."},{"issue":"10","key":"10.1016\/j.bbamcr.2022.119222_bb0140","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1158\/1078-0432.CCR-08-2822","article-title":"Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer","volume":"15","author":"Homma","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbamcr.2022.119222_bb0145","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12885-017-3907-z","article-title":"Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer","volume":"18","author":"Namani","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbamcr.2022.119222_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112503","article-title":"Anti-cancer activity of Conyza blinii saponin against cervical carcinoma through MAPK\/TGF-beta\/Nrf2 signaling pathways","volume":"251","author":"Peng","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"18","key":"10.1016\/j.bbamcr.2022.119222_bb0155","doi-asserted-by":"crossref","first-page":"11908","DOI":"10.1073\/pnas.172398899","article-title":"Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants","volume":"99","author":"Dinkova-Kostova","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbamcr.2022.119222_bb0160","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/cas.14744","article-title":"NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK-NRF2 signaling","volume":"112","author":"Yang","year":"2021","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.bbamcr.2022.119222_bb0165","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3892\/ijmm.2014.1696","article-title":"Mangiferin increases Nrf2 protein stability by inhibiting its ubiquitination and degradation in human HL60 myeloid leukemia cells","volume":"33","author":"Zhao","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.bbamcr.2022.119222_bb0170","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1124\/mol.107.035360","article-title":"Translational control of nrf2 protein in activation of antioxidant response by oxidants","volume":"72","author":"Purdom-Dickinson","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbamcr.2022.119222_bb0175","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/nar\/gkp1048","article-title":"An internal ribosomal entry site mediates redox-sensitive translation of Nrf2","volume":"38","author":"Li","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.bbamcr.2022.119222_bb0180","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","article-title":"Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification","volume":"67","author":"Calderaro","year":"2017","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.bbamcr.2022.119222_bb0185","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1158\/1078-0432.CCR-14-0122","article-title":"Intratumor heterogeneity in hepatocellular carcinoma","volume":"21","author":"Friemel","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bbamcr.2022.119222_bb0190","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ijc.1367","article-title":"Tumor heterogeneity in small hepatocellular carcinoma: analysis of tumor cell proliferation, expression and mutation of p53 AND beta-catenin","volume":"93","author":"An","year":"2001","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbamcr.2022.119222_bb0195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-0676.1987.tb00310.x","article-title":"Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC","volume":"7","author":"Kenmochi","year":"1987","journal-title":"Liver"},{"issue":"10","key":"10.1016\/j.bbamcr.2022.119222_bb0200","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/aps.2018.21","article-title":"Nrf2 mediates the resistance of human A549 and HepG2 cancer cells to boningmycin, a new antitumor antibiotic, in vitro through regulation of glutathione levels","volume":"39","author":"Zhang","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.bbamcr.2022.119222_bb0205","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cell.2015.01.043","article-title":"TGF-beta promotes heterogeneity and drug resistance in squamous cell carcinoma","volume":"160","author":"Oshimori","year":"2015","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.bbamcr.2022.119222_bb0210","doi-asserted-by":"crossref","first-page":"E1818","DOI":"10.1073\/pnas.1402097111","article-title":"Nrf2 target genes can be controlled by neuronal activity in the absence of Nrf2 and astrocytes","volume":"111","author":"Deighton","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"36","key":"10.1016\/j.bbamcr.2022.119222_bb0215","doi-asserted-by":"crossref","first-page":"13568","DOI":"10.1073\/pnas.0806268105","article-title":"Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy","volume":"105","author":"Shibata","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.bbamcr.2022.119222_bb0220","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.celrep.2016.08.010","article-title":"Recurrent loss of NFE2L2 exon 2 is a mechanism for Nrf2 pathway activation in human cancers","volume":"16","author":"Goldstein","year":"2016","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.bbamcr.2022.119222_bb0225","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.18632\/oncotarget.14492","article-title":"Keap1\/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma","volume":"8","author":"Fabrizio","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bbamcr.2022.119222_bb0230","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ncb2021","article-title":"The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1","volume":"12","author":"Komatsu","year":"2010","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.bbamcr.2022.119222_bb0235","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1074\/jbc.M411451200","article-title":"Nrf2 transcriptionally activates the mafG gene through an antioxidant response element","volume":"280","author":"Katsuoka","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"Pt 2","key":"10.1016\/j.bbamcr.2022.119222_bb0240","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/bj3610371","article-title":"Differential induction of mafF, mafG and mafK expression by electrophile-response-element activators","volume":"361","author":"Moran","year":"2002","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.bbamcr.2022.119222_bb0245","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/cm.10138","article-title":"Keap1 in adhesion complexes","volume":"56","author":"Velichkova","year":"2003","journal-title":"Cell Motil. Cytoskeleton"},{"issue":"11","key":"10.1016\/j.bbamcr.2022.119222_bb0250","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/MCB.25.11.4501-4513.2005","article-title":"Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism","volume":"25","author":"Velichkova","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.bbamcr.2022.119222_bb0255","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/03602530600971974","article-title":"Mechanistic studies of the Nrf2-Keap1 signaling pathway","volume":"38","author":"Zhang","year":"2006","journal-title":"Drug Metab. Rev."},{"issue":"3","key":"10.1016\/j.bbamcr.2022.119222_bb0260","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1158\/1541-7786.MCR-17-0544","article-title":"Keap1 inhibits metastatic properties of NSCLC cells by stabilizing architectures of F-actin and focal adhesions","volume":"16","author":"Wu","year":"2018","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbamcr.2022.119222_bb0265","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/s41598-021-81021-0","article-title":"Nrf2 regulates cell motility through RhoA-ROCK1 signalling in non-small-cell lung cancer cells","volume":"11","author":"Ko","year":"2021","journal-title":"Sci. Rep."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488922000131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488922000131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:08:23Z","timestamp":1777500503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488922000131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0167488922000131"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2022.119222","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative subcellular localization of NRF2 and KEAP1 during the hepatocellular carcinoma development in vivo","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2022.119222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119222"}}